These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20471956)

  • 1. Phosphorylation of p300 by ATM controls the stability of NBS1.
    Jang ER; Choi JD; Jeong G; Lee JS
    Biochem Biophys Res Commun; 2010 Jul; 397(4):637-43. PubMed ID: 20471956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetyltransferase p300 regulates NBS1-mediated DNA damage response.
    Jang ER; Choi JD; Lee JS
    FEBS Lett; 2011 Jan; 585(1):47-52. PubMed ID: 21108945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
    Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
    Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATMIN defines an NBS1-independent pathway of ATM signalling.
    Kanu N; Behrens A
    EMBO J; 2007 Jun; 26(12):2933-41. PubMed ID: 17525732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner.
    Gibson SL; Bindra RS; Glazer PM
    Cancer Res; 2005 Dec; 65(23):10734-41. PubMed ID: 16322218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive phosphorylation of ATM in lymphoblastoid cell lines from patients with ICF syndrome without downstream kinase activity.
    Goldstine JV; Nahas S; Gamo K; Gartler SM; Hansen RS; Roelfsema JH; Gatti RA; Marahrens Y
    DNA Repair (Amst); 2006 Apr; 5(4):432-43. PubMed ID: 16426903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ATM-dependent DNA damage signaling pathway.
    Kitagawa R; Kastan MB
    Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response.
    Wu X; Ranganathan V; Weisman DS; Heine WF; Ciccone DN; O'Neill TB; Crick KE; Pierce KA; Lane WS; Rathbun G; Livingston DM; Weaver DT
    Nature; 2000 May; 405(6785):477-82. PubMed ID: 10839545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation.
    Horejsí Z; Falck J; Bakkenist CJ; Kastan MB; Lukas J; Bartek J
    Oncogene; 2004 Apr; 23(17):3122-7. PubMed ID: 15048089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.
    Lim DS; Kim ST; Xu B; Maser RS; Lin J; Petrini JH; Kastan MB
    Nature; 2000 Apr; 404(6778):613-7. PubMed ID: 10766245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of Sp1 in response to DNA damage by ataxia telangiectasia-mutated kinase.
    Olofsson BA; Kelly CM; Kim J; Hornsby SM; Azizkhan-Clifford J
    Mol Cancer Res; 2007 Dec; 5(12):1319-30. PubMed ID: 18171990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of p32 as a novel substrate for ATM in heart.
    Kato H; Takashima S; Asano Y; Shintani Y; Yamazaki S; Seguchi O; Yamamoto H; Nakano A; Higo S; Ogai A; Minamino T; Kitakaze M; Hori M
    Biochem Biophys Res Commun; 2008 Feb; 366(4):885-91. PubMed ID: 18070599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutation at the Nbs1 Threonine 278 site does not affect mouse development, but compromises the Chk2 and Smc1 phosphorylation after DNA damage.
    Li T; Wang ZQ
    Mech Ageing Dev; 2011 Aug; 132(8-9):382-8. PubMed ID: 21664921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM activation by a sulfhydryl-reactive inflammatory cyclopentenone prostaglandin.
    Kobayashi M; Ono H; Mihara K; Tauchi H; Komatsu K; Shibata T; Shimizu H; Uchida K; Yamamoto K
    Genes Cells; 2006 Jul; 11(7):779-89. PubMed ID: 16824197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NBS1 prevents chromatid-type aberrations through ATM-dependent interactions with SMC1.
    Antoccia A; Sakamoto S; Matsuura S; Tauchi H; Komatsu K
    Radiat Res; 2008 Sep; 170(3):345-52. PubMed ID: 18763866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling.
    Biton S; Ashkenazi A
    Cell; 2011 Apr; 145(1):92-103. PubMed ID: 21458669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGA1 protein is a novel target of the ATM kinase.
    Pentimalli F; Palmieri D; Pacelli R; Garbi C; Cesari R; Martin E; Pierantoni GM; Chieffi P; Croce CM; Costanzo V; Fedele M; Fusco A
    Eur J Cancer; 2008 Nov; 44(17):2668-79. PubMed ID: 18783938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals.
    Lou Z; Minter-Dykhouse K; Franco S; Gostissa M; Rivera MA; Celeste A; Manis JP; van Deursen J; Nussenzweig A; Paull TT; Alt FW; Chen J
    Mol Cell; 2006 Jan; 21(2):187-200. PubMed ID: 16427009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.